ACE Gene in Egyptian Ischemic Stroke Patients

Area of Science:

• Genetics
• Cardiovascular Medicine
• Neurology

Background:

• Angiotensin-1-converting enzyme (ACE) plays a key role in vascular health, atherosclerosis, and hypertension.
• The ACE insertion/deletion (I/D) polymorphism is investigated for its potential link to ischemic stroke.
• Understanding this genetic factor's role in different stroke subtypes is crucial.

Purpose of the Study:

• To investigate the association between the ACE gene I/D polymorphism and ischemic stroke in the Egyptian population.
• To determine if the ACE gene I/D polymorphism acts as a risk factor differentiating small-vessel (SV) versus large-vessel (LV) disease.

Main Methods:

• A study involving 60 ischemic stroke patients (30 SV, 30 LV) and 30 healthy controls.
• Clinical assessment, neuroimaging (CT, MRI), and genetic analysis (Polymerase Chain Reaction for ACE gene) were performed.
• Genotyping for the ACE gene I/D polymorphism was conducted on all participants.

Main Results:

• Significant differences in ACE gene polymorphism frequencies were observed across the groups.
• The DD genotype was significantly more prevalent in ischemic stroke patients compared to controls.
• The DD genotype frequency was similar between SV and LV disease patient groups.

Conclusions:

• The ACE gene deletion/deletion (DD) genotype is common in Egyptian patients with non-cardioembolic ischemic stroke.
• The ACE DD genotype is associated with ischemic stroke risk in this population.
• The ACE DD genotype does not appear to be specific to either small-vessel or large-vessel ischemic stroke.